Table 3.
Poor outcome cutoff point
Poor outcome at 12 months | |||||
---|---|---|---|---|---|
| |||||
Cutoff point | AUC [95% CI] | Sensitivity (%) | Specificity (%) | p* | |
Midline shift group | |||||
MLS-V (ml) | >17.464 | 0.831 [0.739-0.900] | 86.1% | 70.7% | 0.318 |
MLS-D (mm) | >9.230 | 0.799 [0.704-0.875] | 63.9% | 84.5% | |
Mild GCS subgroup | |||||
MLS-V (ml) | >9.892 | 0.613 [0.431-0.774] | 66.7% | 90.3% | 0.918 |
MLS-D (mm) | >6.188 | 0.570 [0.389-0.738] | 66.7% | 71.0% | |
Moderate GCS subgroup | |||||
MLS-V (ml) | >22.747 | 0.550 [0.309-0.775] | 100.0% | 50.0% | 0.861 |
MLS-D (mm) | >6.426 | 0.593 [0.348-0.808] | 100.0% | 35.7% | |
Severe GCS subgroup | |||||
MLS-V (ml) | >27.353 | 0.854 [0.709-0.945] | 71.4% | 100.0% | 0.030 |
MLS-D (mm) | >11.859 | 0.736 [0.575-0.861] | 53.6% | 92.3% |
The tests were significant at P<0.05.